Literature DB >> 10839194

Urate attenuates oxidation of native low-density lipoprotein by hypochlorite and the subsequent lipoprotein-induced respiratory burst activities of polymorphonuclear leukocytes.

S Kopprasch1, K Richter, W Leonhardt, J Pietzsch, J Grässler.   

Abstract

Oxidation converts native low-density lipoprotein (LDL) into a signal molecule promoting inflammatory processes during atherogenesis. The exact contribution of different antioxidants in prevention of LDL oxidation is not known. Uric acid efficiently scavenges oxidants including hypochlorite. We investigated the effect of different urate concentrations (25-500 micromol/l) on the oxidation of isolated native LDL by sodium hypochlorite (1000 micromol/l). While relative electrophoretic mobility declined continuously with increasing urate concentrations in the oxidation medium, lipid peroxidation as measured by TBARS was blunted only at high molar urate/NaOCl ratios. By decreasing oxidative modifications, urate dose-dependently (beginning with a urate/NaOCl ratio of 1:40) diminished stimulatory effects of oxidized LDL on the respiratory burst of resting polymorphonuclear leukocytes (PMNL). Protecting effects of urate against the proinflammatory action of oxidized LDL on activated cells were evident only at a molar urate/NaOCl ratio of 1:2 suggesting different sensitivities of PMNL to LDL oxidation state in dependence on their activity state.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10839194     DOI: 10.1023/a:1007025318306

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

1.  Oxidation and antioxidation of human low-density lipoprotein and plasma exposed to 3-morpholinosydnonimine and reagent peroxynitrite.

Authors:  S R Thomas; M J Davies; R Stocker
Journal:  Chem Res Toxicol       Date:  1998-05       Impact factor: 3.739

2.  How different constituents of human plasma and low density lipoprotein determine plasma oxidizability by copper.

Authors:  T Spranger; B Finckh; R Fingerhut; A Kohlschütter; U Beisiegel; A Kontush
Journal:  Chem Phys Lipids       Date:  1998-01       Impact factor: 3.329

3.  Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells.

Authors:  S Kopprasch; W Leonhardt; J Pietzsch; H Kühne
Journal:  Atherosclerosis       Date:  1998-02       Impact factor: 5.162

4.  Simultaneous measurement of allantoin, uric acid, xanthine and hypoxanthine in blood by high-performance liquid chromatography.

Authors:  M Czauderna; J Kowalczyk
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1997-12-19

5.  Hypochlorite-modified LDL: chemotactic potential and chemokine induction in human monocytes.

Authors:  C Woenckhaus; A Kaufmann; D Bussfeld; D Gemsa; H Sprenger; H J Gröne
Journal:  Clin Immunol Immunopathol       Date:  1998-01

Review 6.  Towards the physiological function of uric acid.

Authors:  B F Becker
Journal:  Free Radic Biol Med       Date:  1993-06       Impact factor: 7.376

7.  The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma.

Authors:  D D Wayner; G W Burton; K U Ingold; L R Barclay; S J Locke
Journal:  Biochim Biophys Acta       Date:  1987-06-22

8.  Conformational changes in oxidized LDL recognized by mouse peritoneal macrophages.

Authors:  R Maeba; H Shimasaki; N Ueta
Journal:  Biochim Biophys Acta       Date:  1994-11-17

9.  Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.

Authors:  B N Ames; R Cathcart; E Schwiers; P Hochstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

10.  Human suction blister interstitial fluid prevents metal ion-dependent oxidation of low density lipoprotein by macrophages and in cell-free systems.

Authors:  A J Dabbagh; B Frei
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.